Going it aloneGot to be honest, as someone who only found out about the company 6 months ago and bought in at $0.30, I was kind of hopeful of a buyout. Even at $1.50 I would have been quite chuffed. I think this financing and the fact that they delayed BLA submission to improve their manufactoring facility tells all of us that the company either want to go it alone, or can't find a suitable buyer to take it from here. This is obviously risky but the rewards in the long run would be astronomcial, baring FDA approval. Then again I suppose many offers will flood in should we get said approval and a buyout could happen then. It's tough sitting on the sidelines wathcing things slowly unfold when the potential payout is so big. I just hope the people running the show have some sense of what they're doing. They better submit in Q2 or they'll be trouble for us all.